India plans a new support scheme for bulk drugs focused on R&D and capacity creation, while ruling out a broad medicine price hike despite rising input costs
Popular Posts
-
CREA says most sulphur dioxide emissions around Delhi-NCR come from coal-fired power plants exempt from installing FGD systems, urging stric...
-
Apple and Tata Electronics tell MeitY no significant data was lost in the alleged breach, says secretary S Krishnan
